Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension
Approval is the culmination of 10 years of clinical research and development of the Medtronic renal denervation technology
Source: dicardiology.com
📰 Global Clinical Program News
Global Clinical Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Global Clinical Program. Real-time updates on events, politics, business and more.
FDA OKs Symplicity Renal Denervation System for Hypertension
After a mixed FDA panel review in August, the agency has approved Medtronics Symplicity Spyral renal denervation system for treatment of hypertension.
Raymond Townsend David Kandzari Medtronic Symplicity Spyral Symplicity Spyral Otsuka Medical Devices Co Ltd Recor Medical Inc
Source: medscape.com
Medtronic announces FDA approval of minimally invasive device to treat hypertension
The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the...
United States David Kandzari Krystin Hayward Symplicity Spyral Medtronic Symplicity Ryan Weispfenning
Source: marketscreener.com
Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System
/PRNewswire/ -- Today, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review...
Jason Weidman Medtronic Symplicity Spyral Ryan Weispfenning David Kandzari Krystin Hayward Leong Cardiovascular Services
Source: prnewswire.com
EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range
Press release content from PR Newswire. The AP news staff was not involved in its creation.
United States France General Jason Weidman Medtronic Symplicity Spyral Symplicity Spyral Felix Mahfoud
Source: apnews.com
New data on significant blood pressure reduction
Medtronic plc today announced long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial, which were presented today at the American College
United States Jason Weidman Medtronic Symplicity Spyral Symplicity Spyral Jeffrey Popma Felix Mahfoud
Source: eturbonews.com
ACC.22: Medtronic renal denervation system demonstrates significant blood pressure reduction through three years
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced long-term data from the first 80 patients in the SPYRAL...
United States Jason Weidman Medtronic Symplicity Spyral Symplicity Spyral Felix Mahfoud Coll Cardiol
Source: prnewswire.com
Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced findings from a new study of the Patient Preferences for...
Source: prnewswire.com
Medtronic study shows patients with high blood pressure are interested in an interventional procedure treatment option
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced findings from a new study of the Patient Preferences for...
Source: prnewswire.com